Thema: EGS38341C011
AXPH, EGS38341C011
finance-6097979_1920.jpg - Foto: THN
Alexandria Pharmaceuticals stock: AGM resolutions published
Alexandria Pharmaceuticals stock gains a fresh governance reference after its annual meeting resolutions were published. The filing keeps investor focus on AXPH.
ad-hoc-news.de, vor 24 Minuten
AXPH, EGS38341C011
Alexandria reports EGP 524.80 million profit: what it means ...
Audited profit reached EGP 524.80 million in fiscal year 2025/2026, up 34.16 percent. Alexandria Pharmaceuticals stock has an EGP 1,987.00 high.
ad-hoc-news.de, 19.10.26 02:01 Uhr
AXPH, EGS38341C011
Alexandria posts growth. Alexandria Pharmaceuticals stock ...
Alexandria Pharmaceuticals earned EGP 524.80 million in fiscal 2025/2026, up 34.16 percent. A 15.49 P/E values Alexandria Pharmaceuticals stock.
ad-hoc-news.de, 14.10.26 04:38 Uhr
AXPH, EGS38341C011
Alexandria Pharmaceuticals stock stayed 23.94 percent below ...
Alexandria Pharmaceuticals stock was last at EGP 1,511.26 on October 6, 2026, below its EGP 1,987.00 yearly high. Audited profit rose 34.16 percent.
ad-hoc-news.de, 08.10.26 02:34 Uhr
AXPH, EGS38341C011
AXPH stock trades without a verified market catalyst
AXPH stock had no substantiated price record in the September 23, 2026 market snapshot. Its latest report and next dated event remain the key reference points.
ad-hoc-news.de, 23.09.26 12:57 Uhr
